Key result
Non-specific intraventricular conduction delay in ACS patients was associated with a higher risk of cardiac mortality compared to no IVCD (SDH 2.68; 95% CI 2.19-3.27).
Why the study?
Initial proof suggests non-specific intraventricular conduction delay is a risk factor for mortality, but the prognosis of intraventricular conduction delays including NIVCD in ACS patients required further exploration.
Does the presence of intraventricular conduction delays predict cardiac mortality in patients with acute coronary syndrome?
Cohort (n=9,749)
Yes
Does the presence of intraventricular conduction delays predict cardiac mortality in patients with acute coronary syndrome?
Effect estimate: SDH 2.68 (95% CI 2.19-3.27)
Absolute Event Rate: 76.9% vs 50.1%
Intraventricular conduction delays, particularly non-specific IVCD, are strong independent predictors of long-term cardiac mortality in patients with acute coronary syndrome.
AIMS: Initial proof suggests that a non-specific intraventricular conduction delay (NIVCD) is a risk factor for mortality. We explored the prognosis of intraventricular conduction delays (IVCD)-right bundle branch block (RBBB), left bundle branch block (LBBB), and the lesser-known NIVCD-in patients with acute coronary syndrome (ACS). METHODS AND RESULTS: This is a retrospective registry analysis of 9749 consecutive ACS patients undergoing coronary angiography and with an electrocardiographic (ECG) recording available for analysis (2007-18). The primary outcome was cardiac mortality. Mortality and cause of death data (in ICD-10 format) were received from the Finnish national register with no losses to follow-up (until 31 December 2020). The risk associated with IVCDs was analysed by calculating subdistribution hazard estimates (SDH; deaths due to other causes being considered competing events). The mean age of the population was 68.3 years [standard deviation (Sd) 11.8]. The median follow-up time was 6.1 years [interquartile range (IQR) 3.3-9.4], during which 3156 patients died. Cardiac mortality was overrepresented among IVCD patients: 76.9% for NIVCD (n = 113/147), 67.6% for LBBB (n = 96/142), 55.7% for RBBB (n = 146/262), and 50.1% for patients with no IVCD (n = 1275/2545). In an analysis adjusted for age and cardiac comorbidities, the risk of cardiac mortality was significantly higher in all IVCD groups than among patients with no IVCD: SDH 1.37 (1.15-1.64, P < 0.0001) for RBBB, SDH 1.63 (1.31-2.03 P < 0.0001) for LBBB, and SDH 2.68 (2.19-3.27) for NIVCD. After adjusting the analysis with left ventricular ejection fraction, RBBB and NIVCD remained significant risk factors for cardiac mortality. CONCLUSION: RBBB, LBBB, and NIVCD were associated with higher cardiac mortality in ACS patients.
No takes yet. Share an insight, caveat, or question.
Lahti et al. (2023) conducted a cohort in Acute coronary syndrome (n=9,749). Non-specific intraventricular conduction delay (NIVCD) vs. No intraventricular conduction delay was evaluated on Cardiac mortality (SDH 2.68, 95% CI 2.19-3.27). Non-specific intraventricular conduction delay in ACS patients was associated with a higher risk of cardiac mortality compared to no IVCD (SDH 2.68; 95% CI 2.19-3.27).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: